Evaluation of an Unconventional Cancer Treatment (The Di Bella Multitherapy): Results of Phase II Trials in Italy
BMJ: British Medical Journal 1999 January 23; 318(7178): 224-228
Showing items related by title, author, creator and subject.
The Evaluation of the Risks and Benefits of Phase II Cancer Clinical Trials by Institutional Review Boards (IRB) Members: A Case Study van Luijn, H.E.M.; Aaronson, N.K.; Keus, R.B.; Musschenga, A.W. (2006-03)There are indications that institutional review board (IRB) members do not find it easy to assess the risks and benefits in medical experiments, although this is their principal duty. This study examined how IRB members ...